Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk
Kristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)
|
May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial
Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Journal of the American College of Cardiology
|
December 15, 2015
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya
Cynthia A Binanay, Constantine O Akwanalo, Wilson Aruasa, et al.
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
The Lancet. HIV
|
April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
Triin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk
Kristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)
|
May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial
Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Journal of the American College of Cardiology
|
December 15, 2015
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya
Cynthia A Binanay, Constantine O Akwanalo, Wilson Aruasa, et al.
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
The Lancet. HIV
|
April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
Triin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
Page
of 19